Feature | Contrast Media Injectors | January 19, 2022 | By Melinda Taschetta-Millane

The contrast media injectors market is anticipated to grow with a CAGR of 6.1% during the forecast period of 2021-2026

In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.

In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.


Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives.

The contrast media injectors market is anticipated to grow with a CAGR of 6.1% during the forecast period of 2021-2026, according to a new report from Mordor Intelligence.1 Some major factors attributing to the growth of this market include increasing demand for minimally invasive surgeries, technological advancements and the increasing number of regulatory approvals. However, the rising cost of contrast media injectors could obstruct some segments of the market due to budgetary issues with smaller hospitals.

Most companies are developing innovative products to reduce contrast media waste and gain a competitive advantage. Bracco has developed smart syringeless injectors, which are able to use every drop of contrast loaded into the system for maximum economy. The smart injectors record the amount injected and imaging protocol used, and send that information to the PACS. These constant technological advancements in the contrast media injector technology are expected to boost the contrast media injector market during the forecast period.2

Utilizing Information Technology

Key contrast injector market players are emphasizing the production of IT-enabled contrast media injectors to help eliminate human error. Several contrast media injectors are currently available that can be connected to the hospital’s server to access patient data. Interfacing can be done through the electronic medical record system or hospital information system to monitor and adjust the dose. Future Market Insights predicts that this precision is likely to drive the market during the forecast period.2

Key Market Trends

The Mordor Intelligence report identified these key upcoming trends in contrast media injector systems that are expected to help the market grow over the forecasted period:

•Computed tomography (CT) injectors are expected to grow positively as the usage of the CT systems has been increasing from the past few years, and these CT systems use a dual-head injector, with two syringes for initial and follow-up contrast doses, during imaging. There has been constant R&D activity by major academic centers and pharmaceutical companies to develop protocols, which helps CT users with the advanced capabilities of newer imaging systems. The integration of IT and contrast media dose management are prospective growth factors for the forecast period.

•Manufacturers of CT and automated contrast injectors are partnering to better integrate their systems. This includes contrast dose tracking. Mallinckrodt has launched an OptiSync data management system, which is designed to collect and analyze radiology data when a patient undergoes a contrast-media-enhanced CT imaging procedure.

Technical Services and Support

In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions. The suite of technical services and support is designed for all Guerbet injectors, with three offerings ranging from preventive maintenance to full equipment protection including service continuity. 

Personalized Imaging

Bayer’s Medrad Stellant Flex CT injection system offers Bayer’s CT injection technology with a user-driven design, minimal required technologist training and automation that drives individualized patient protocols and personalized imaging. With this injector, Bayer said it addresses the changing U.S. healthcare environment, which has seen an overall decrease in capital funding. This often results in reduced operational budgets for hospitals, creating the need for institutions to work more efficiently and economically, while maintaining quality patient care. The Medrad Stellant Flex CT injection system was designed to help address these clinical and financial challenges.

Workflow Efficiencies

GE Healthcare has been working with ulrich medical to deliver the ulrich CTmotion in the United States since 2019. The CTmotion supports workflow efficiencies, including quick and easy set-up and patient turnover. The injector can help remove the need for manual syringe filling, which can minimize examination preparation time and minimize contrast media waste. 

Nemoto Kyorindo offers contrast media injectors for CT, magnetic resonance imaging (MRI) and angiography. Customizable protocols give radiologists the opportunity to tailor programs for any diagnostic objective. The company’s MRI injectors use non-ferrous construction to allow for safe integration in the MRI room. 

References:

1.https://www.mordorintelligence.com/industry-reports/contrast-media-injectors-market. Accessed Jan. 11, 2022.

2. https://www.futuremarketinsights.com/reports/contrast-media-injectors-market. Accessed Jan. 11, 2022.

 

View the Contrast Media Injectors comparison chart here

 


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
Videos | RSNA

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about ...

Time February 07, 2024
arrow
News | ACR

February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...

Time February 06, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
News | Artificial Intelligence

February 1, 2024 — Nearly 8,000 veterans are diagnosed with lung cancer each year. Now at-risk veterans will have access ...

Time February 01, 2024
arrow
News | Lung Imaging

January 25, 2024 — According to the American Journal of Roentgenology (AJR), high-frequency jet ventilation appears to ...

Time January 25, 2024
arrow
Subscribe Now